Drug Shortage Report for GLUCOBAY
Report ID | 155283 |
Drug Identification Number | 02190893 |
Brand name | GLUCOBAY |
Common or Proper name | ACARBOSE |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ACARBOSE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 120's |
ATC code | A10BF |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-04-15 |
Actual start date | 2022-03-16 |
Estimated end date | Unknown |
Actual end date | 2023-07-10 |
Shortage status | Resolved |
Updated date | 2023-07-11 |
Company comments | DIN discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-07-11 | English | Compare |
v7 | 2023-07-10 | French | Compare |
v6 | 2023-07-10 | English | Compare |
v5 | 2022-03-17 | French | Compare |
v4 | 2022-03-17 | English | Compare |
v3 | 2022-03-17 | English | Compare |
v2 | 2022-02-18 | French | Compare |
v1 | 2022-02-18 | English | Compare |
Showing 1 to 8 of 8